MOH
MOLINA HEALTHCARE, INC.Marquee-fund ownership over time
This quarter's activity
New positions opened
Positions exited
None.
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Maverick Capital re-entered | Q4 2018 | 31Q | $127 | $185 | +46% |
| Bridgewater Associates re-entered | Q2 2022 | 17Q | $296 | $185 | -38% |
| Renaissance Technologies | Q3 2024(8Q snapshot) | 7Q | $338 | $185 | -45% |
| Citadel Advisors re-entered | Q3 2024(8Q snapshot) | 7Q | $339 | $185 | -45% |
| Two Sigma Investments re-entered | Q3 2024(8Q snapshot) | 7Q | $339 | $185 | -45% |
| D.E. Shaw | Q3 2024(8Q snapshot) | 7Q | $339 | $185 | -45% |
| AQR Capital Management | Q3 2024(8Q snapshot) | 7Q | $339 | $185 | -45% |
| Millennium Management | Q3 2024(8Q snapshot) | 7Q | $339 | $185 | -45% |
| Scion Asset Management re-entered | Q3 2024 | 7Q | $339 | $185 | -45% |
| Point72 Asset Management re-entered | Q4 2024(8Q snapshot) | 6Q | $306 | $185 | -40% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Viking Global Investors 4× in & out | Q3 2025 | Q4 2025 | → $138 | -14% |
| Glenview Capital | Q2 2020 | Q1 2022 | → $308 | +70% |
| Coatue Management | Q1 2020 | Q2 2020 | → $181 | +25% |
| JANA Partners | Q3 2017 | Q2 2018 | → $85 | +48% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at MOLINA HEALTHCARE, INC.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from May 15, 2026 — the most recent Form 4 on file — not from today.
- Form 40001267043-26-000004May 15, 2026
- Form 40001555603-26-000004May 13, 2026
- Form 40001233184-26-000007May 8, 2026
- Form 40001257996-26-000004Apr 2, 2026
- Form 40001856013-26-000004Apr 2, 2026
- Form 40001211493-26-000004Apr 2, 2026
- Form 40001228861-26-000004Apr 2, 2026
- Form 40001263714-26-000006Apr 2, 2026
- Form 40001649773-26-000004Apr 2, 2026
- Form 40001169490-26-000004Apr 2, 2026
- Form 40001206684-26-000006Apr 2, 2026
- Form 40001206684-26-000004Mar 13, 2026
- Form 40001320929-26-000002Mar 2, 2026
- Form 40001690677-26-000002Mar 2, 2026
- Form 40001213947-26-000002Mar 2, 2026
Fundamentals
XBRL · MOLINA HEALTHCARE, INC.Annual figures sourced directly from MOLINA HEALTHCARE, INC.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for MOLINA HEALTHCARE, INC. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KMaterial eventMay 11, 2026
- 8-KFORM 8-KMay 8, 2026
- 10-QQuarterly reportApr 23, 2026
- 8-KMaterial eventApr 22, 2026
- DEF 14AProxy statementMar 23, 2026
- 8-KFORM 8-KFeb 26, 2026
- 10-KAnnual reportFeb 10, 2026
- 8-KFORM 8-KFeb 6, 2026
- 8-KMaterial eventFeb 5, 2026
- 8-KFORM 8-KNov 20, 2025
- 8-KFORM 8-KNov 18, 2025
- 8-KFORM 8-KNov 17, 2025
- 8-KFORM 8-KNov 14, 2025
- 10-QQuarterly reportOct 23, 2025
- 8-KMaterial eventOct 22, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Maverick Capital | Q2 2026 | open | $185 | $178 | -4% |
| Point72 Asset Management | Q1 2026 | open | $136 | $185 | +36% |
| Scion Asset Management | Q4 2025 | open | $147 | $185 | +26% |
| Citadel Advisors | Q3 2025 | open | $160 | $185 | +16% |
| Viking Global Investors | Q3 2025 | Q4 2025 | $160 | $138 | -14% |
| Point72 Asset Management | Q3 2025 | Q4 2025 | $160 | $138 | -14% |
| Two Sigma Investments | Q1 2025 | open | $272 | $185 | -32% |
| Point72 Asset Management | Q4 2024 | Q1 2025 | $306 | $272 | -11% |
| Citadel Advisors | Q3 2024 | Q2 2025 | $339 | $314 | -7% |
| Two Sigma Investments | Q3 2024 | Q4 2024 | $339 | $306 | -10% |
| D.E. Shaw | Q3 2024 | open | $339 | $185 | -45% |
| AQR Capital Management | Q3 2024 | open | $339 | $185 | -45% |
| Millennium Management | Q3 2024 | open | $339 | $185 | -45% |
| Scion Asset Management | Q3 2024 | Q2 2025 | $339 | $314 | -7% |
| Renaissance Technologies | Q3 2024 | open | $338 | $185 | -45% |
| Maverick Capital | Q2 2024 | Q4 2024 | $346 | $306 | -12% |
| Bridgewater Associates | Q1 2023 | open | $299 | $178 | -41% |
| Maverick Capital | Q4 2022 | Q4 2023 | $315 | $363 | +15% |
| Bridgewater Associates | Q2 2022 | Q3 2022 | $296 | $328 | +11% |
| Maverick Capital | Q3 2021 | Q2 2022 | $253 | $304 | +20% |
| Maverick Capital | Q4 2020 | Q2 2021 | $219 | $262 | +20% |
| Glenview Capital | Q2 2020 | Q1 2022 | $181 | $308 | +70% |
| Maverick Capital | Q2 2020 | Q3 2020 | $181 | $194 | +7% |
| Coatue Management | Q1 2020 | Q2 2020 | $145 | $181 | +25% |
| Viking Global Investors | Q4 2019 | Q3 2023 | $122 | $320 | +163% |
| Maverick Capital | Q2 2019 | Q4 2019 | $130 | $122 | -6% |
| Maverick Capital | Q4 2018 | Q1 2019 | $127 | $136 | +7% |
| Viking Global Investors | Q3 2017 | Q2 2018 | $58 | $85 | +48% |
| JANA Partners | Q3 2017 | Q2 2018 | $58 | $85 | +48% |
| Viking Global Investors | Q4 2014 | Q1 2015 | $49 | $60 | +24% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.